Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Nicotine for the Treatment of Pain Associated With Chemotherapy-Induced Peripheral Neuropathy

NCT04468230 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT04468230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04468230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Nicotine for the Treatment of Pain Associated With Chemotherapy-Induced Peripheral Neuropathy
Lead sponsor
Virginia Commonwealth University
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2020
Completion date
May 31, 2022
Enrollment
4 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced peripheral neuropathy, neuropathic pain, neuropathy, peripheral neuropathy